Evonik is restructuring to focus on its strategic core growth areas. Learn about its plan. ➡️ https://hubs.li/Q02T6SFw0 #pharmanews #lifesciences
Contract Pharma
Media Production
Montvale, New Jersey 9,321 followers
From drug development to manufacturing, we cover the latest developments, views & opinions from the pharma industry
About us
CONTRACT PHARMA is the multi media information outlet dedicated to bio/pharma outsourcing. From drug development to manufacturing, we cover the latest developments, views and opinions from industry leaders in print and online. CONTRACT PHARMA offers advertising opportunities in our print magazine, Contract Pharma Direct weekly e newsletter and on contractpharma.com. We are the only worldwide print publication focused on Bio/Pharma contract services, delivering a total qualified circulation of 20,013. (VAC audit statement) On Sept. 26-27, 2024 CONTRACT PHARMA will host its 23rd Annual Contracting & Outsourcing Conference & Tabletop Exhibition. This event brings together speakers from the FDA, industry leaders, and expert analysts to discuss issues critical to success for Pharma & Biopharma outsourcing. The one-day Tabletop Exhibition of 160 top contract service providers provides great exposure to outsourcing decision makers. CONTRACT PHARMA's Corporate Capabilities and Contract Services Directory is the largest single source for company profiles and contract services. This standalone print issue showcases the services of Bio/Pharma contract service providers. The Contract Services Directory is also available online at www.contractpharma.com/csd. It's an indispensable guide for contract services in print and online. Every week, thousands of Bio/Pharma outsourcing professionals go to www.contractpharma.com to read current features, find archive stories, and get breaking news and online exclusives. We also e-mail CONTRACT PHARMA DIRECT, our weekly e-newsletter, to more than 20,000 people. CPDirect is filled with the latest news, our most recent articles, and links to our popular annual features and upcoming meetings. Free subscriptions are available on our website. Contact us for more information on how your company can get involved with Contract Pharma.
- Website
-
http://www.contractpharma.com/
External link for Contract Pharma
- Industry
- Media Production
- Company size
- 11-50 employees
- Headquarters
- Montvale, New Jersey
- Type
- Privately Held
- Specialties
- Pharma, Contract Manufacturing, Pharmaceuticals, news, and marketing
Locations
-
Primary
25 Philips Pkwy
Montvale, New Jersey 07645, US
Employees at Contract Pharma
Updates
-
Syngene International Ltd. is an integrated research, development, and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors. Syngene's more than 6,000 scientists offer both skills and the capacity to deliver great science, robust data security, and quality manufacturing, at speed, to improve time-to-market and lower the cost of innovation. 👉 Learn more: https://hubs.li/Q02Smlly0 Sponsored by Syngene International Limited
-
A lot can happen in one year, especially in a fast-paced industry like the pharmaceutical industry. Discover more about the 2024 mergers and acquisitions happening in the pharmaceutical industry within our new eBook with nanoComposix, a Fort Life Sciences company! Download the eBook today to read more: https://hubs.li/Q02S-Y-X0 Sponsored by nanoComposix | Fortis Life Sciences
-
Matica Biotechnology Inc., a CDMO specializing in viral vector manufacturing, has entered a strategic development partnership with CytoImmune, a biotechnology company that focuses on innovative cell therapies for cancer treatment. ➡️ https://hubs.li/Q02T344T0 #pharmanews #biotech #CDMO
-
Cellipont Bioservices, a cell therapy CDMO, and Mongoose Bio, a biopharma company pioneering precision T-cell based therapies targeting solid cancers, signed an agreement for the technology transfer, process development, and cGMP manufacture of its autologous MGB-001 TCR-T cell therapy program. https://hubs.li/Q02SXTBJ0
-
At Avema Pharma Solutions we foresee a transformative shift in the pharmaceutical landscape, where the expanding gummy sector parallels the substantial growth experienced in the nutritional supplement market. Appealing attributes of gummies, position our CDMO at the forefront of this evolution in drug development! Learn more>> https://hubs.li/Q02SM6TH0 Sponsored by Avema Pharma Solutions
-
Join Sentry BioPharma Services, Inc.'s VP of Operations, Alex T. Mitchell, for this captivating Q&A. Dive into the various options Sentry Biopharma offers in terms of temperature-controlled systems, the importance of end-to-end cold chain, its extensive security measures, & more! Read Now>> https://hubs.li/Q02S0nK30 Sponsored by Sentry BioPharma Services, Inc.
-
Join Element Materials Technology for their upcoming webinar on Tuesday, October 15th @ 2:00pm EST! Essential sterility & mycoplasma testing are critical to preventing contamination that could compromise patient outcomes/product integrity. With the rise of personalized medicine, the ability to quickly & accurately identify contaminants not only streamlines the manufacturing process but also aligns with stringent regulatory requirements. Don't Miss Out!! Learn More>> https://hubs.li/Q02SRr870 Sponsored by Element Materials Technology
-
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, has opened its new €290 million biosafety testing facility in Rockville, MD. ➡️ https://hubs.ly/Q02SP-k90 #pharmanews #lifescience #biosafety
-
Eli Lilly and Company has appointed Thomas J. Fuchs as its first chief AI officer. Read more about his responsibilities in this newly created role. ➡️ https://hubs.li/Q02SLvmH0 #pharmanews #AI #ML